# Eveliqure Biotechnologies GMBH

Canonical: https://abierto.us/vendors/eveliqure-biotechnologies-gmbh-zkejw1jekbq9

- UEI: ZKEJW1JEKBQ9
- CAGE: 6311N
- Location: Wien, AUT
- Awards in window: 1 (10 transactions), $4,881,502 obligated, June 3, 2024 to March 31, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $4,881,502

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $4,881,502

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93020C00048 (definitive contract): $4,881,502, National Institutes of Health Niaid. To Advance the Development of the Shigetec Vaccine Through CGMP Manufacturing and Release of Additional CGMP Lots for Use in a Series of Phase 2 Clinical Trials.. https://www.usaspending.gov/award/CONT_AWD_75N93020C00048_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/eveliqure-biotechnologies-gmbh-zkejw1jekbq9.